WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1994014433) COMBINATION OF A CHOLESTEROL BIOSYNTHESIS INHIBITOR AND A $g(b)-LACTAM CHOLESTEROL ABSORPTION INHIBITOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1994/014433    International Application No.:    PCT/US1993/012291
Publication Date: 07.07.1994 International Filing Date: 21.12.1993
Chapter 2 Demand Filed:    21.06.1994    
IPC:
A61K 31/395 (2006.01)
Applicants: SCHERING CORPORATION [US/US]; 200 Galloping Hill Road, Kenilworth, NJ 07033 (US) (For All Designated States Except US).
DAVIS, Harry, R. [US/US]; (US) (For US Only)
Inventors: DAVIS, Harry, R.; (US)
Agent: MAGATTI, Anita, W.; Schering-Plough Corporation, Patent Dept. K-6-1 1990, 2000 Galloping Hill Road, Kenilworth, NJ 07033-0530 (US)
Priority Data:
07/995,488 23.12.1992 US
Title (EN) COMBINATION OF A CHOLESTEROL BIOSYNTHESIS INHIBITOR AND A $g(b)-LACTAM CHOLESTEROL ABSORPTION INHIBITOR
(FR) COMBINAISON D'UN INHIBITEUR DE BIOSYNTHESE DU CHOLESTEROL ET D'UN INHIBITEUR D'ABSORPTION DU CHOLESTEROL BETA-LACTAME
Abstract: front page image
(EN)Methods of reducing plasma cholesterol levels and treating or preventing atherosclerosis comprising administering an effective amount of a combination of a cholesterol biosynthesis inhibitor and a $g(b)-lactam cholesterol absorption inhibitor, as well as pharmaceutical compositions and kits useful in those methods, are disclosed.
(FR)L'invention se rapporte à des procédés de réduction des taux de cholestérol dans le plasma et de traitement ou prévention de l'athérosclérose, et qui consistent à administrer une quantité efficace d'une combinaison d'un inhibiteur de biosynthèse du cholestérol et d'un inhibiteur d'absorption du cholestérol $g(b)-lactame. L'invention se rapporte également à des compositions pharmaceutiques et à des kits utilisés dans ces procédés.
Designated States: AU, BB, BG, BR, BY, CA, CZ, FI, HU, JP, KR, KZ, LK, LV, MG, MN, MW, NO, NZ, PL, RO, RU, SD, SK, UA, US, UZ, VN.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)